A. Bertomoro

发表

S. Ferrari, A. Lombardi, I. Cortella, 2021 .

Frequent but low titre factor VIII inhibitors in haemophilia A patients treated with high purity concentrates.

A. Bertomoro, A. Girolami, E. Zanon, 1999, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Acquired von Willebrand syndrome in patients with monoclonal gammopathy of undetermined significance investigated using a mechanistic approach.

A. Bertomoro, F. Galvanin, E. Galletta, 2021, Blood transfusion = Trasfusione del sangue.

Diagnostic Value of Measuring Platelet Von Willebrand Factor in Von Willebrand Disease

P. Prandoni, A. Bertomoro, V. Daidone, 2016, PloS one.

An apparently silent nucleotide substitution (c.7056C>T) in the von Willebrand factor gene is responsible for type 1 von Willebrand disease

A. Bertomoro, V. Daidone, A. Casonato, 2011, Haematologica.

Type 1 von Willebrand disease due to reduced von Willebrand factor synthesis and/or survival: observations from a case series.

A. Bertomoro, R. Padrini, V. Daidone, 2010, Translational research : the journal of laboratory and clinical medicine.

Reduced survival of type 2B von Willebrand factor, irrespective of large multimer representation or thrombocytopenia

Alessandra Casonato, A. Bertomoro, R. Padrini, 2010, Haematologica.

A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor.

A. Bertomoro, R. Padrini, V. Daidone, 2008, Blood.

An Arg760Cys mutation in the consensus sequence of the von Willebrand factor propeptide cleavage site is responsible for a new von Willebrand disease variant.

A. Bertomoro, A. Girolami, A. Casonato, 2003, Blood.

Von Willebrand factor collagen binding activity in the diagnosis of von Willebrand disease: an alternative to ristocetin co‐factor activity?

A. Bertomoro, A. Girolami, A. Casonato, 2001, British journal of haematology.

Congenital deficiencies and abnormalities of prothrombin.

A. Bertomoro, A. Girolami, B. Girolami, 1998, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Type IIB von Willebrand Disease: Role of Qualitative Defects in Atherosclerosis and Endothelial Dysfunction

A. Bertomoro, A. Girolami, E. Zanon, 2007, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Re-evaluation of the therapeutic efficacy of DDAVP in type IIB von Willebrand's disease.

A. Bertomoro, A. Girolami, P. Zerbinati, 1994, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

EDTA dependent pseudothrombocytopenia caused by antibodies against the cytoadhesive receptor of platelet gpIIB-IIIA.

A. Bertomoro, A. Girolami, A. Casonato, 1994, Journal of clinical pathology.

Eltrombopag for the treatment of inherited thrombocytopenias: a phase II clinical trial

P. Noris, A. Bertomoro, F. Fabris, 2019, Haematologica.

Coagulation Activation in Children with Sickle Cell Disease Is Associated with Cerebral Small Vessel Vasculopathy

G. Basso, A. Bertomoro, R. Manara, 2013, PloS one.

A novel von Willebrand factor mutation (I1372S) associated with type 2B-like von Willebrand disease: An elusive phenotype and a difficult diagnosis

A. Bertomoro, V. Daidone, A. Casonato, 2007, Thrombosis and Haemostasis.

Combined partial exon skipping and cryptic splice site activation as a new molecular mechanism for recessive type 1 von Willebrand disease

A. Bertomoro, L. Bartoloni, A. Casonato, 2006, Thrombosis and Haemostasis.

Abnormal collagen binding activity of 2A von Willebrand factor: evidence that the defect depends only on the lack of large multimers.

A. Bertomoro, A. Girolami, P. Zerbinati, 1997, The Journal of laboratory and clinical medicine.

Abnormally large von Willebrand factor multimers in Henoch‐Schönlein purpura

A. Bertomoro, A. Girolami, E. Ossi, 1996, American journal of hematology.

Fainting induces an acute increase in the concentration of plasma factor VIII and von Willebrand factor.

A. Bertomoro, A. Girolami, A. Casonato, 2003, Haematologica.

Focus on Key Issues in Immune Thrombotic Thrombocytopenic Purpura: Italian Experience of Six Centers

G. Tiscia, E. Grandone, A. Ostuni, 2021, Journal of Clinical Medicine.

Type 2M von Willebrand disease variant characterized by abnormal von willebrand factor multimerization.

A. Bertomoro, A. Girolami, A. Casonato, 2001, The Journal of laboratory and clinical medicine.

Identifying type Vicenza von Willebrand disease.

A. Rosato, A. Bertomoro, R. Padrini, 2006, The Journal of laboratory and clinical medicine.

New heterozygous variant in GP1BB gene is responsible for an inherited form of macrothrombocytopenia

S. Ferrari, A. Lombardi, I. Cortella, 2019, British journal of haematology.

Do Hemophilia A and von Willebrand Disease Protect Against Carotid Atherosclerosis? A Comparative Study Between . Coagulopathics and Normal Subjects by Means of Carotid Echo-Color Doppler Scan

A. Bertomoro, A. Girolami, E. Zanon, 1999, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Lack of multimer organization of von Willebrand factor in an acquired von Willebrand syndrome

A. Bertomoro, A. Doria, A. Girolami, 2002, British journal of haematology.

A phase III study comparing secondary long-term prophylaxis versus on-demand treatment with vWF/FVIII concentrates in severe inherited von Willebrand disease.

A. Iorio, A. Bertomoro, V. Jiménez‐Yuste, 2019, Blood transfusion = Trasfusione del sangue.

Associated risk factors and arterial occlusions in patients with von Willebrand disease: Analysis of the literature and report of two cases

S. Ferrari, A. Bertomoro, A. Girolami, 2014 .

Spectrum of 5’UTR mutations in ANKRD26 gene in patients with inherited thrombocytopenia: c.-140C>G mutation is more frequent than expected

S. Ferrari, A. Lombardi, I. Cortella, 2017, Platelets.

Identifying Carriers of Type 2N von Willebrand Disease

A. Bertomoro, P. Perutelli, A. Casonato, 2007, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Pregnancy‐induced worsening of thrombocytopenia in a patient with type IIB von Willebrand's disease

A. Bertomoro, A. Girolami, A. Casonato, 1991, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Spontaneous recurrent intracranial haemorrhage in a woman with type 2B von Willebrand disease: A clinical case and a brief literature review

A. Bertomoro, P. Simioni, S. Pasca, 2019, Haemophilia : the official journal of the World Federation of Hemophilia.

The Bleeding Assessment Tool and laboratory data in the characterisation of a female with inherited haemophilia A.

A. Bertomoro, E. Galletta, V. Daidone, 2016, Blood transfusion = Trasfusione del sangue.

A 29-year-old woman with persistent thrombocytopenia

A. Bertomoro, F. Fabris, F. Boscaro, 2019, Internal and Emergency Medicine.

Type 2B von Willebrand disease with or without large multimers: A distinction of the two sides of the disorder is long overdue

A. Bertomoro, E. Galletta, V. Daidone, 2017, PloS one.

Different organization of von Willebrand factor oligomers in type-2A and -2B von Willebrand disease variants: effects of DDAVP infusion and protease inhibitors

A. Bertomoro, A. Girolami, M. Zaninotto, 1995, Annals of Hematology.

TYPE I PADUA: A NEW VARIANT OF VON WILLEBRAND'S DISEASE

A. Bertomoro, A. Girolami, A. Casonato, 1992, British Journal of Haematology.

Platelet-Derived Microparticles Bearing PF4 and Anti-GAGS Immunoglobulins in Patients with Sepsis

A. Bertomoro, F. Fabris, P. Simioni, 2020, Diagnostics.

Combined Factor V and Factor VII Deficiency Due to an Independent Segregation of the Two Defects

A. Bertomoro, A. Girolami, E. Zanon, 1999, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Which Assay Is the Most Suitable to Investigate von Willebrand Factor Functional Activity ?

A. Bertomoro, A. Girolami, A. Casonato, 1999, Thrombosis and Haemostasis.

A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers.

A. Bertomoro, A. Girolami, A. Casonato, 1994, Haematologia.

Link between von Willebrand factor multimers, relapses and coronary microcirculation in patients with thrombotic thrombocytopenic purpura in remission.

A. Lombardi, A. Bertomoro, F. Fabris, 2019, Thrombosis research.

Right‐sided non‐recurrent laryngeal nerve without any vascular anomaly: an anatomical trap

J. Saiz, S. Ferrari, A. Lombardi, 2021, ANZ journal of surgery.

Rituximab‐induced acute and delayed serum sickness in thrombotic thrombocytopenic purpura: the role of anti‐rituximab antibodies

S. Ferrari, A. Lombardi, I. Cortella, 2019, British journal of haematology.

An Arg760Cys mutation in the consensus sequence of the von Willebrand factor propeptide cleavage site is responsible for a new von Willebrand disease variant.

A. Bertomoro, A. Girolami, A. Casonato, 2003 .